While lower BRD2 expression predicted better survival in the total medulloblastoma cohort, lower BRD2 expression was not significantly associated with better survival in the SHH subgroup (Fig. 3G; Supplementary Fig. S4B). Here, BRD2 is linked to medulloblastoma.